Sitaxentan

DB06268

small molecule approved investigational withdrawn

Deskripsi

Sitaxentan was marketed under the trade name Thelin for the treatment of pulmonary arterial hypertension (PAH) by Encysive Pharmaceuticals until Pfizer purchased Encysive in February 2008. In 2010, Pfizer voluntarily removed sitaxentan from the market over concerns of hepatotoxicity.

Struktur Molekul 2D

Berat 454.905
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) 10 hours
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

70-100%

Metabolisme

Hepatic (CYP2C9- and CYP3A4-mediated)

Rute Eliminasi

Renal (50 to 60%) Fecal (40 to 50%)

Interaksi Makanan

1 Data
  • 1. Take with or without food.

Interaksi Obat

1017 Data
Cyclosporine The risk or severity of adverse effects can be increased when Cyclosporine is combined with Sitaxentan.
Cilostazol The serum concentration of Cilostazol can be increased when it is combined with Sitaxentan.
Amifostine Sitaxentan may increase the hypotensive activities of Amifostine.
Diazoxide Diazoxide may increase the hypotensive activities of Sitaxentan.
Methylphenidate Methylphenidate may decrease the antihypertensive activities of Sitaxentan.
Dexmethylphenidate Dexmethylphenidate may decrease the antihypertensive activities of Sitaxentan.
Obinutuzumab Sitaxentan may increase the hypotensive activities of Obinutuzumab.
Pentoxifylline Pentoxifylline may increase the hypotensive activities of Sitaxentan.
Rituximab Sitaxentan may increase the hypotensive activities of Rituximab.
Desmopressin Desmopressin may decrease the antihypertensive activities of Sitaxentan.
Midodrine Midodrine may decrease the antihypertensive activities of Sitaxentan.
Isoetharine Isoetharine may decrease the antihypertensive activities of Sitaxentan.
Atomoxetine Atomoxetine may decrease the antihypertensive activities of Sitaxentan.
Etomidate Etomidate may decrease the antihypertensive activities of Sitaxentan.
Zolmitriptan Zolmitriptan may decrease the antihypertensive activities of Sitaxentan.
Protriptyline Protriptyline may decrease the antihypertensive activities of Sitaxentan.
Norepinephrine Norepinephrine may decrease the antihypertensive activities of Sitaxentan.
Phenylephrine Phenylephrine may decrease the antihypertensive activities of Sitaxentan.
Phenylpropanolamine Phenylpropanolamine may decrease the antihypertensive activities of Sitaxentan.
Droperidol Droperidol may decrease the antihypertensive activities of Sitaxentan.
Amoxapine Amoxapine may decrease the antihypertensive activities of Sitaxentan.
Doxapram Doxapram may decrease the antihypertensive activities of Sitaxentan.
Atropine Atropine may decrease the antihypertensive activities of Sitaxentan.
Metaraminol Metaraminol may decrease the antihypertensive activities of Sitaxentan.
Sumatriptan Sumatriptan may decrease the antihypertensive activities of Sitaxentan.
Nicergoline Nicergoline may decrease the antihypertensive activities of Sitaxentan.
Methoxamine Methoxamine may decrease the antihypertensive activities of Sitaxentan.
Propiomazine Propiomazine may decrease the antihypertensive activities of Sitaxentan.
Orciprenaline Orciprenaline may decrease the antihypertensive activities of Sitaxentan.
Phenmetrazine Phenmetrazine may decrease the antihypertensive activities of Sitaxentan.
Trifluoperazine Trifluoperazine may decrease the antihypertensive activities of Sitaxentan.
Dobutamine Dobutamine may decrease the antihypertensive activities of Sitaxentan.
Pseudoephedrine Pseudoephedrine may decrease the antihypertensive activities of Sitaxentan.
Ritodrine Ritodrine may decrease the antihypertensive activities of Sitaxentan.
Terbutaline Terbutaline may decrease the antihypertensive activities of Sitaxentan.
Flupentixol Flupentixol may decrease the antihypertensive activities of Sitaxentan.
Bitolterol Bitolterol may decrease the antihypertensive activities of Sitaxentan.
Diethylpropion Diethylpropion may decrease the antihypertensive activities of Sitaxentan.
Naratriptan Naratriptan may decrease the antihypertensive activities of Sitaxentan.
Rizatriptan Rizatriptan may decrease the antihypertensive activities of Sitaxentan.
Dopamine Dopamine may decrease the antihypertensive activities of Sitaxentan.
Frovatriptan Frovatriptan may decrease the antihypertensive activities of Sitaxentan.
Albuterol Salbutamol may decrease the antihypertensive activities of Sitaxentan.
Isoprenaline Isoprenaline may decrease the antihypertensive activities of Sitaxentan.
Arbutamine Arbutamine may decrease the antihypertensive activities of Sitaxentan.
Lisdexamfetamine Lisdexamfetamine may decrease the antihypertensive activities of Sitaxentan.
Fenoterol Fenoterol may decrease the antihypertensive activities of Sitaxentan.
Pirbuterol Pirbuterol may decrease the antihypertensive activities of Sitaxentan.
Ephedra sinica root Ephedra sinica root may decrease the antihypertensive activities of Sitaxentan.
Ephedrine Ephedrine may decrease the antihypertensive activities of Sitaxentan.
Mephentermine Mephentermine may decrease the antihypertensive activities of Sitaxentan.
Procaterol Procaterol may decrease the antihypertensive activities of Sitaxentan.
Methotrimeprazine Methotrimeprazine may decrease the antihypertensive activities of Sitaxentan.
Clenbuterol Clenbuterol may decrease the antihypertensive activities of Sitaxentan.
Bambuterol Bambuterol may decrease the antihypertensive activities of Sitaxentan.
MMDA MMDA may decrease the antihypertensive activities of Sitaxentan.
Midomafetamine Midomafetamine may decrease the antihypertensive activities of Sitaxentan.
2,5-Dimethoxy-4-ethylamphetamine 2,5-Dimethoxy-4-ethylamphetamine may decrease the antihypertensive activities of Sitaxentan.
4-Methoxyamphetamine 4-Methoxyamphetamine may decrease the antihypertensive activities of Sitaxentan.
4-Bromo-2,5-dimethoxyamphetamine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Sitaxentan.
Tenamfetamine Tenamfetamine may decrease the antihypertensive activities of Sitaxentan.
Chlorphentermine Chlorphentermine may decrease the antihypertensive activities of Sitaxentan.
Dextroamphetamine Dextroamphetamine may decrease the antihypertensive activities of Sitaxentan.
Metamfetamine Metamfetamine may decrease the antihypertensive activities of Sitaxentan.
Phendimetrazine Phendimetrazine may decrease the antihypertensive activities of Sitaxentan.
Periciazine Periciazine may decrease the antihypertensive activities of Sitaxentan.
Acepromazine Acepromazine may decrease the antihypertensive activities of Sitaxentan.
Thioproperazine Thioproperazine may decrease the antihypertensive activities of Sitaxentan.
Epicaptopril Epicaptopril may decrease the antihypertensive activities of Sitaxentan.
1-benzylimidazole 1-benzylimidazole may decrease the antihypertensive activities of Sitaxentan.
Amineptine Amineptine may decrease the antihypertensive activities of Sitaxentan.
Amibegron Amibegron may decrease the antihypertensive activities of Sitaxentan.
Naluzotan Naluzotan may decrease the antihypertensive activities of Sitaxentan.
Pizotifen Pizotifen may decrease the antihypertensive activities of Sitaxentan.
Solabegron Solabegron may decrease the antihypertensive activities of Sitaxentan.
Droxidopa Droxidopa may decrease the antihypertensive activities of Sitaxentan.
Esmirtazapine Esmirtazapine may decrease the antihypertensive activities of Sitaxentan.
Nitrous oxide Nitrous oxide may decrease the antihypertensive activities of Sitaxentan.
Xylometazoline Xylometazoline may decrease the antihypertensive activities of Sitaxentan.
Isometheptene Isometheptene may decrease the antihypertensive activities of Sitaxentan.
Levonordefrin Levonordefrin may decrease the antihypertensive activities of Sitaxentan.
Naphazoline Naphazoline may decrease the antihypertensive activities of Sitaxentan.
Saralasin Saralasin may decrease the antihypertensive activities of Sitaxentan.
Tetryzoline Tetryzoline may decrease the antihypertensive activities of Sitaxentan.
Cinitapride Cinitapride may decrease the antihypertensive activities of Sitaxentan.
Tyramine Tyramine may decrease the antihypertensive activities of Sitaxentan.
Adrafinil Adrafinil may decrease the antihypertensive activities of Sitaxentan.
Ifenprodil Ifenprodil may decrease the antihypertensive activities of Sitaxentan.
Hexoprenaline Hexoprenaline may decrease the antihypertensive activities of Sitaxentan.
Etilefrine Etilefrine may decrease the antihypertensive activities of Sitaxentan.
Dimetacrine Dimetacrine may decrease the antihypertensive activities of Sitaxentan.
Butriptyline Butriptyline may decrease the antihypertensive activities of Sitaxentan.
Cirazoline Cirazoline may decrease the antihypertensive activities of Sitaxentan.
Synephrine Synephrine may decrease the antihypertensive activities of Sitaxentan.
Moxisylyte Moxisylyte may decrease the antihypertensive activities of Sitaxentan.
Oxaprotiline Oxaprotiline may decrease the antihypertensive activities of Sitaxentan.
Iofetamine I-123 Iofetamine I-123 may decrease the antihypertensive activities of Sitaxentan.
Racepinephrine Racepinephrine may decrease the antihypertensive activities of Sitaxentan.
DL-Methylephedrine DL-Methylephedrine may decrease the antihypertensive activities of Sitaxentan.
Amitraz Amitraz may decrease the antihypertensive activities of Sitaxentan.

Target Protein

Endothelin-1 receptor EDNRA
Endothelin receptor type B EDNRB

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 6 • International brands: 0
Produk
  • Thelin
    Tablet • 100 mg • Oral • Canada • Approved
  • Thelin
    Tablet, film coated • 100 mg • Oral • EU
  • Thelin
    Tablet, film coated • 100 mg • Oral • EU
  • Thelin
    Tablet, film coated • 100 mg • Oral • EU
  • Thelin
    Tablet, film coated • 100 mg • Oral • EU
  • Thelin
    Tablet, film coated • 100 mg • Oral • EU

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul